Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01360099 · ClinicalTrials.gov registry record

Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study

A clinical trial, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

Completed
Registry status
120
Enrollment target

NCT01360099 is a clinical trial that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01360099 has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

COMPLETED
Registry status
120 participants
Enrollment target

Study Summary

Background: \- Osteoporosis is a condition where the bone becomes more brittle and more likely to break as a person ages. The drugs that people take to treat this condition have prevented many common hip fractures. But these drugs may be associated with problems in the shape and structure of the hip bone after many years of use. These changes in the hip bone may lead to an unusual kind of hip fracture. These fractures are very rare, so it is hard to study them. Researchers want to learn more about these fractures. Objectives: \- To compare hip x-rays of three groups: people who have been taking osteoporosis drugs for several years, those who have just started taking them, and those who have never taken these drugs. Eligibility: * People at least 50 years of age who have been taking osteoporosis drugs for at least 5 years. * People at least 50 years of age who have been taking these drugs for less than 1 year. * People at least 50 years of age who have never taken these drugs. Design: * All participants will have three total visits over 3 years. * At the first visit, those taking part will have a medical history and physical exam. They will complete a questionnaire about medication use and bone health. They will also have an x-ray of the hips and pelvis, and have a bone density scan (the kind used to test for osteoporosis) of the hips. Those in the study will repeat these exams and medical history questions at followup visits. These visits will take place 18 months and 36 months after the first study visit. * At any of these visits, participants who may have a hip fracture that does not show up on the x-rays will have an imaging study to examine the bone more closely. * Participants who receive a hip replacement or suffer from a broken bone at any time should inform the study researchers as soon as possible.

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2011-05-04
Est. Completion 2017-01-11

What the Registry Record Tells You About NCT01360099

The ClinicalTrials.gov registry entry for NCT01360099 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01360099 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01360099 about?

NCT01360099 is a clinical study titled "Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study". Background: \- Osteoporosis is a condition where the bone becomes more brittle and more likely to break as a person ages. The drugs that people take to treat this condition have prevented many common hip fractures. But these drugs may be associated with problems in the shape and structure of the hi...

What is the current status of trial NCT01360099?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2011-05-04. Estimated completion is 2017-01-11.

Who is sponsoring clinical trial NCT01360099?

This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.